Washington, DC (June 3, 2009) – The National Osteoporosis Foundation (NOF) (www.nof.org), the nation’s leading voluntary health organization solely dedicated to osteoporosis and bone health and EmpowHer, the home of women’s health online, (www.empowher.com), are working together in a formal collaboration to advance women’s health. As part of their innovative partnership, NOF and EmpowHer will increase awareness of osteoporosis and bone health. The two organizations will reach women through EmpowHer’s online community, NOF’s web site, e-Newsletter mentions and reciprocal Web site linking.
“There are an estimated 44 million Americans with or at risk for osteoporosis,” said Leo Schargorodski, Executive Director of the National Osteoporosis Foundation (NOF). “NOF is proud to partner with EmpowHer to help increase awareness of osteoporosis and bone health and provide many of these individuals with information, resources and a forum for dialogue about the disease.”
"EmpowHer is thrilled to partner with the National Osteoporosis Foundation," said Michelle King Robson, Founder and Chairman of EmpowHer. "Their longstanding dedication to improving the bone health of women through increased research, education and advocacy is making a tremendous impact on women around the world. This is exactly the type of partnership that helps improve the health and well-being of the women in EmpowHer’s global audience."
About the National Osteoporosis Foundation
The National Osteoporosis Foundation is the nation’s leading voluntary health organization solely dedicated to osteoporosis and bone health. NOF’s mission is to prevent osteoporosis and related fractures, to promote lifelong bone health, to help improve the lives of those affected by osteoporosis and to find a cure through programs of awareness, advocacy, public and health professional education and research.
About EmpowHer
EmpowHer is a unique resource dedicated to improving women’s health and well-being. EmpowHer provides up-to-date medical information, access to leading medical experts, advocates, and a devoted community of women who ask questions, share stories, and connect with one another in a safe and supportive environment.
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.